Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari

  Рет қаралды 4,764

OncBrothers: Practice-Changing Cancer Discussions

OncBrothers: Practice-Changing Cancer Discussions

Күн бұрын

Пікірлер: 1
@Anikayy
@Anikayy 4 ай бұрын
Great overview, it would be great to have one final summary slide.
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
20:25
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 3,1 М.
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
19:14
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,3 М.
UFC 310 : Рахмонов VS Мачадо Гэрри
05:00
UFC 310 : Рахмонов VS Мачадо Гэрри
Setanta Sports UFC
Рет қаралды 1,2 МЛН
Quando A Diferença De Altura É Muito Grande 😲😂
00:12
Quando A Diferença De Altura É Muito Grande 😲😂
Mari Maria
Рет қаралды 45 МЛН
Đang ngồi chơi bỗng dưng bể cá vỡ kính, may có CCTV chứng minh sự trong sạch cho cô bé
00:27
Đang ngồi chơi bỗng dưng bể cá vỡ kính, may có CCTV chứng minh sự trong sạch cho cô bé
Tiin_vn - Viettel Media
Рет қаралды 28 МЛН
When you have a very capricious child 😂😘👍
00:16
When you have a very capricious child 😂😘👍
Like Asiya
Рет қаралды 18 МЛН
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
17:57
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,6 М.
Lung cancer update, survival rates improving
13:04
Lung cancer update, survival rates improving
Upstate Medical University
Рет қаралды 5 М.
Podcasts in NSCLC Harboring EGFR Mutations: Cutting-Edge Reports from ASCO 2024 - Episode 1
12:20
Podcasts in NSCLC Harboring EGFR Mutations: Cutting-Edge Reports from ASCO 2024 - Episode 1
Practice Point Communications
Рет қаралды 133
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
23:22
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,8 М.
Comedy Club: Измена во сне | Демис Карибидис, Марина Кравец @ComedyClubRussia
16:29
Comedy Club: Измена во сне | Демис Карибидис, Марина Кравец @ComedyClubRussia
Comedy Club
Рет қаралды 2 МЛН
Стыдные вопросы про Китай / вДудь
3:07:50
Стыдные вопросы про Китай / вДудь
вДудь
Рет қаралды 2,4 МЛН
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
18:00
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,2 М.
2nd line treatment in advanced HCC and when to switch
26:19
2nd line treatment in advanced HCC and when to switch
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,5 М.
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
23:25
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,5 М.
ASCO 2024 Top 5 Melanoma & Immunotherapy Abstracts with Omid Hamid, MD
8:49
ASCO 2024 Top 5 Melanoma & Immunotherapy Abstracts with Omid Hamid, MD
OncologyTube
Рет қаралды 1 М.
UFC 310 : Рахмонов VS Мачадо Гэрри
05:00
UFC 310 : Рахмонов VS Мачадо Гэрри
Setanta Sports UFC
Рет қаралды 1,2 МЛН